Angiopoietin‐like protein 4 and clinical outcomes in ischemic stroke patients [PDF]
Annals of Clinical and Translational Neurology, 2021 Aims Angiopoietin‐like protein 4 (ANGPTL‐4) had been reported to be associated with the risk of ischemic stroke, but its prognostic value remained unclear.
Xiaowei Zheng +13 more
doaj +2 more sources
Angiopoietin‐Like Protein 4 Is a High‐Density Lipoprotein (HDL) Component for HDL Metabolism and Function in Nondiabetic Participants and Type‐2 Diabetic Patients [PDF]
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017 BackgroundANGPTL4 (angiopoietin‐like protein 4) is a LPL (lipoprotein lipase) inhibitor and is present in high‐density lipoprotein (HDL). However, it is not defined whether ANGPTL4 in HDLs could affect HDL metabolism and function in type 2 diabetes ...
Long‐Yan Yang +7 more
doaj +4 more sources
Angiopoietin-like protein 4 regulates breast muscle lipid metabolism in broilers [PDF]
Poultry Science, 2021 : The objective of this study was to determine the effects of angiopoietin-like protein 4 (ANGPTL4) on breast muscle lipid metabolism in broilers. In experiment 1, 36 thirty-five-day-old male Arbor Acres broilers were randomly allocated into 6 treatment ...
Xu Zhao +5 more
doaj +2 more sources
Angiopoietin-Like Protein 4 and Insulin-Like Growth Factor-1 Expression in Invasive Breast Carcinoma in Young Women [PDF]
Pathophysiology, 2022 Biomarker identification is imperative for invasive breast carcinoma, which is more aggressive and associated with higher mortality and worse prognosis in younger patients (50 years).
Zaleha Kamaludin +4 more
doaj +2 more sources
The angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritis [PDF]
Arthritis Research & Therapy, 2022 Background Modulators of triglyceride metabolism include lipoprotein lipase (LPL), angiopoietin-like protein 4 (ANGPTL4), and apolipoprotein C-3 (ApoC3).
Laura de Armas-Rillo +7 more
doaj +2 more sources
Kidney angiopoietin-like protein 4 regulates fibrotic responses in diabetic kidney disease [PDF]
Frontiers in PharmacologyThe angiopoietin-like (ANGPTL) proteins are now recognized as critical regulators of the harmful changes seen in diabetic kidney disease. Notably, a hyposialylated pro-proteinuric form of ANGPTL4 has been identified as a crucial contributor to fibrosis ...
Swayam Prakash Srivastava +9 more
doaj +2 more sources
Angiopoietin-Like Protein 4 May Be an Interplay Between Serum Uric Acid and Triglyceride-Rich Lipoprotein Cholesterol [PDF]
Frontiers in Cardiovascular Medicine, 2022 BackgroundAlthough the available evidence has indicated a link between elevated serum uric acid (SUA) level and dyslipidemia, the potential contribution of SUA on lipid profiles remains unclear.
Yani Peng +5 more
doaj +2 more sources
A Review of free fatty acid-induced cell signaling, angiopoietin-like protein 4, and skeletal muscle differentiation [PDF]
Frontiers in Physiology, 2022 Postnatal skeletal muscle differentiation from quiescent satellite cells is a highly regulated process, although our understanding of the contribution of nutritional factors in myogenesis is limited. Free fatty acids (FFAs) are known to cause detrimental
Yura Son, Chad M. Paton, Chad M. Paton
doaj +2 more sources
Serum Angiopoietin‐Like Protein 4 as a Biomarker for Acute Ischemic Stroke Severity and Dynamic Changes [PDF]
Brain and BehaviorBackground Angiopoietin‐like protein 4 (ANGPTL4) is critical for vascular integrity and reducing inflammation in ischemic and hypoxic brain injuries. However, limited studies have evaluated ANGPTL4's role in acute ischemic stroke (AIS) assessment, and ...
Fang Guo +6 more
doaj +2 more sources
Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic target [PDF]
Frontiers in PharmacologyThe global burden of renal diseases is increasingly severe, underscoring the need for in-depth exploration of the molecular mechanisms underlying renal disease progression and the development of potential novel biomarkers or therapeutic targets ...
Yan Li +14 more
doaj +2 more sources